Hosted on MSN1mon
Royalty Pharma simplifies corporate structure with $1.1 billion dealRoyalty Pharma said its decision follows feedback from investors that the current structure made it difficult to invest in the healthcare firm, and shifting to an internal management could enhance ...
Royalty Pharma agreed to acquire its external manager, RP Management, in a $1.1 billion deal that it believes will pay for itself in the long-term as it aims to simplify its corporate structure.
Royalty Pharma said its decision follows feedback from investors that the current structure made it difficult to invest in the healthcare firm, and shifting to an internal management could enhance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results